Wendan Yu
- Molecular Biology top 10%
- Oncology top 10%
- Cancer Research top 5%
- Endocrine and Autonomic Systems top 5%
- Immunology
- Co-authors
- Wuguo DengWei GuoWenlin HuangXiangsheng XiaoWangbing ChenShilei ZhaoRanran TangZhenglin Li
- Topics
- RNA modifications and cancer (8 papers)Estrogen and related hormone effects (7 papers)Genomics and Chromatin Dynamics (6 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Wendan Yu
48 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 940
- Oncology 336
- Cancer Research 315
- Endocrine and Autonomic Systems 163
- Immunology 141
Countries citing papers authored by Wendan Yu
This map shows the geographic impact of Wendan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendan Yu more than expected).
Fields of papers citing papers by Wendan Yu
This network shows the impact of papers produced by Wendan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendan Yu. The network helps show where Wendan Yu may publish in the future.
Co-authorship network of co-authors of Wendan Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Wendan Yu. A scholar is included among the top collaborators of Wendan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendan Yu. Wendan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 7 | |
| 4 | 7 | |
| 5 | 19 | |
| 6 | 10 | |
| 7 | 27 | |
| 8 | 22 | |
| 9 | 19 | |
| 10 | 28 | |
| 11 | 29 | |
| 12 | 36 | |
| 13 | 35 | |
| 14 | 64 | |
| 15 | 24 | |
| 16 | 69 | |
| 17 | 59 | |
| 18 | Fisetin Simultaneously Targets Apaf-1, ERK, and COX-2 Signaling Leading to Growth Inhibition and Apoptosis in Human Cervical Carcinoma Cell In Vitro | 1 |
| 19 | 19 | |
| 20 | 62 |
About Wendan Yu
Wendan Yu is a scholar working on Cancer Research, Toxicology and Molecular Biology, having authored 50 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Estrogen and related hormone effects (7 papers) and Genomics and Chromatin Dynamics (6 papers). The work is most often cited by research in Endocrine and Autonomic Systems (163 citations), Cancer Research (315 citations) and Biological Psychiatry (35 citations). Wendan Yu has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Wuguo Deng, Wei Guo, Wenlin Huang, Xiangsheng Xiao, Wangbing Chen, Shilei Zhao, Ranran Tang, Zhenglin Li, Sheng Hu and Jingshu Wang. Their work appears in journals such as PLoS ONE, Free Radical Biology and Medicine and PLoS Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.